Another risky one but with a new income stream things are looking up for Sun.
Why they did not perform better last year is anyones guess.
I suppose the big boys have been let down before but this time its different .
Take a look - long term holder.....

Slow and steady, just how I like it!

Still going up (just).

RNS Number : 8595K

Surgical Innovations Group PLC

22 July 2011


For immediate release 22 July 2011

Surgical Innovations Group plc

("SI" or "the Group")

SI extends distribution agreement with SI US for a further 5 years

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, announces that it has signed a 5 year extension to its agreement with SI US, the Group's exclusive US Master distributor. In order to maintain exclusive rights, SI US has committed to distribute SI branded products to a minimum value of $8.0 million to Surgical Innovations over the 5 year period.

SI US will distribute the Logi(R)Range and LogiCut(R) product range together with the reusable line and has been granted first refusal to all future SI branded products within the agreement period. The Group retains the right to manufacture and distribute all devices under the SI brand in all other markets.

Graham Bowland, Chief Executive Officer of SI, said: "This agreement extension with SI US strengthens the Group's strategy of developing its Resposable(R) portfolio in the strategically important US market and gives us confidence for the future. We look forward to developing our partnership with SI US over the next 5 years."

RNS Number : 1201L

Surgical Innovations Group PLC

27 July 2011


For immediate release 27 July 2011

Surgical Innovations Group plc

("SI" or "the Group")

SI signs exclusive five-year distribution agreement with CareFusion for its new advanced laparoscopic retractor, Pretzel-Flex(R)

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, announces it has signed heads of terms to enter into a five-year exclusive distribution agreement with CareFusion (NYSE: CFN), a leading, global medical device company, for its new advanced Pretzel-Flex(R) laparoscopic retractor.

Under the distribution agreement, CareFusion has acquired exclusive U.S. rights to Pretzel-Flex(R) for five years. Surgical Innovations will manufacture the device for CareFusion and will be marketed in the U.S. under the CareFusion brand. SI retains the right to manufacture and distribute the device, under the SI brand in all other markets.

The patented Pretzel-Flex(R) has been developed by SI for the effective retraction or repositioning of large organs, such as the liver, to provide proper access and visualisation during complex minimally invasive surgery (MIS). A common use of the device is in the retraction of the liver during a gastric bypass. For this type of operation the liver must be moved (retracted) in order to obtain access to the upper stomach. The Pretzel-Flex(R) makes it much easier for doctors to retract large or swollen livers that are common in obese individuals.

The second-generation innovative design gives added strength to the flexible segment technology that SI originally developed for its leading EndoFlex(R) retractor that was previously licensed to CareFusion. The technology allows the instrument to meet unique surgical challenges by enabling the surgeon to insert the instrument through a small port access system, no more than 5mm, into the abdomen before activating a predetermined shape. The Pretzel-Flex(R) has been so named because its predetermined shape is similar to that of a pretzel.

Greater strength has become a necessary requirement for retractors and SI has met the challenge of creating a retractor that meets the opposing demands for smaller devices, such as 3mm percutaneous instruments, and for the ability to gently reposition organs that have become steadily larger in obese patients over recent years.

Graham Bowland, chief executive officer of SI, said: "This latest agreement with CareFusion affirms a long standing and successful partnership and gives Pretzel-Flex(R) access to an established U.S. sales force that is already well versed with our flex technology."

"The new Pretzel-Flex(R) laparoscopic retractor is a strong, complementary fit with our current portfolio of minimally invasive surgical products", said Jim Leitl, senior vice president and general manager of Medical Specialties, Medical Technologies & Services for CareFusion."

A close above 12 here would be good - interims on 14th September.

Might get there today!

Scorchio!

good day here

Muy scorchio!

Sorry - my mistake - interims were on the 14th LAST September. Still awaiting imminent RNS to give this years date!

(Gasps of horror!) ;o)

Sorry Kim :-) Some reasonable trades have gone through today. Close well above 12.

'S ok Skinny, I've got over the shock now! :o)

Another good sunny day!

24 August 2011

Surgical Innovations Group plc

("SI" or "the Group")

Notice of Results

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices, will announce its results for the six months ended 30 June 2011 on Wednesday 14 September 2011.

An analyst presentation will take place at 9:30 am on 14 September 2011 at the offices of Seymour Pierce Limited, 20 Old Bailey, London, EC4M 7EN.

You were right in the end skinny! :o)

RNS Number : 3798N

Advanced Medical Solutions Grp PLC

01 September 2011

For immediate release: 1 September 2011

Advanced Medical Solutions Group plc

("AMS" or the "Company")

Development and Pre-Supply Agreement signed with Surgical Innovations Group plc

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, today announces that it has signed a Development and Pre-Supply Agreement ("the Agreement") with Surgical Innovations Group plc ("Surgical Innovations") (AIM: SUN), for the development and supply of a novel device for internal application of adhesives and sealants.

Under the terms of the Agreement, Surgical Innovations will develop and retain the intellectual property rights for a unique applicator to deliver accurately, individual drops of adhesive or sealant internally within the body, accessed via a minimally invasive surgical port site. In return for the exclusive rights to this applicator for the internal application of adhesives and sealants, AMS has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years.

The development of the internal applicator is a key step in extending the Company's expertise in adhesives and sealants from purely topical applications to also addressing clinical needs inside the body. AMS has previously highlighted that the first target internal application would be the hernia mesh fixation market which is currently served by sutures, staples and tacks. This new internal applicator, together with the Company's adhesives, will allow AMS to address this important market with reduced surgical complications.

Commenting on this announcement, Chris Meredith, Chief Executive Officer of AMS said:

"This agreement combines our formulation and regulatory expertise with Surgical Innovations' applicator design and manufacturing expertise to introduce a new product to a global market for internal sealants that is now in excess of US$600 million. As we have previously indicated, an integral part of our tissue sealant and adhesives R&D is focused on moving our product range more towards the Operating Room, including internal applications. In this regard, we are optimistic that our partnership with Surgical Innovations will give us a market leading product, targeting the hernia mesh fixation market, which should be available for launch in 2013."

Graham Bowland, Chief Executive Office of Surgical Innovations added:

"Our agreement with AMS affirms SI's reputation in delivering leading design solutions to OEM customers. The applicator device for AMS is a natural extension to our existing minimally invasive surgical product portfolio and we have already commenced on the design work on a fully disposable device. As part of the agreement SI will retain the full intellectual property rights to the applicator device and will also manufacture it on behalf of AMS."

Half Yearly Report.

RNS Number : 1861O

Surgical Innovations Group PLC

14 September 2011


14 September 2011

Surgical Innovations Group plc

("SI" or "the Group")

Interim Results

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative medical devices for minimally invasive surgery ("MIS"), is pleased to announce its interim results for the six months ended 30 June 2011.

Financial highlights

-- Revenues of GBP3.20 million (H1 2010: GBP3.57 million)

-- Operating profit of GBP514,000 (H1 2010: GBP781,000)

-- Pre-tax profit of GBP474,000 (H1 2010: GBP766,000)

-- GBP1.36 million invested in manufacturing, research and development during the period

-- Gross margins in core MIS business increased to 42% (H1 2010: 35%)

-- Net cash of GBP594,000 generated from operating activities

-- Basic earnings per share of 0.12p (H1 2010: 0.18p)

Operational highlights

-- Current trading is encouraging with strong customer demand across the business

-- SI branded products up 29% to GBP2.05 million (H1 2010: GBP1.59 million)

-- Strong demand from OEM partners for R&D expertise

-- Increased penetration of Resposable(R) products will result in increased demand for high margin disposable parts going forward

-- Development of 3mm instrument range and devices for hip arthroscopy underway

-- Two major new product launches to take place in second half of the year: Pretzel-Flex(TM) and Optical Trocar for YelloPort+plus(R)

Skinny,

what do you think about SUN in light of the report?
DO you hold it?

ahoj - I sold back in June @10.1 having held for (ever) years. I keep watching as I think they are a good company, and will buy back at some point. They have had a reasonably good news flow recently and Graham Bowland seems credible. I believe there was an investor presentation this morning, so maybe worth seeing the outcome.

Surgical Innovations Group PLC

01 November 2011


For immediate release 1 November 2011

Surgical Innovations Group plc

("SI" or "the Group")

SI receives confirmation of successful RGF bid

Surgical Innovations Group (AIM: SUN), the designer and manufacturer of innovative medical devices, is pleased to announce that it has received confirmation from the Department of Business, Innovation and Skills, that it is one of 119 successful bids in the UK in the second round of the Government's GBP1.4 billion Regional Growth Fund.

The Regional Growth Fund (RGF) is a GBP1.4bn fund operating across England from 2011 to 2014. It supports projects and programs that lever private sector investment creating economic growth and sustainable employment. It aims particularly to help those areas and communities currently dependent on the public sector to make the transition to sustainable private sector-led growth and prosperity.

SI has received a conditional offer, subject to due diligence, which has been earmarked for job creation, apprenticeships, training, development of innovative medical devices and manufacturing infrastructure. The quantum of the funding to SI remains confidential at this stage of the process.

As part of the bid process, SI has committed to continue its own program of investment in the business, creating direct jobs and increasing the number of apprenticeships it offers over a three year period.

Commenting on this announcement, Graham Bowland, Chief Executive Officer of SI said:

"This is a significant boost for the Group and we are incredibly pleased that our bid has been successful. This funding will allow us to invest heavily in the business and its future growth through product innovation, manufacturing equipment and employment."

For more information on the Regional Growth Fund please visit: http://www.bis.gov.uk/policies/regional-economic-development/regional-growth-fund

- ends -